PortfoliosLab logoPortfoliosLab logo
DVXV vs. BBP
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

DVXV vs. BBP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WEBs Health Care XLV Defined Volatility ETF (DVXV) and Virtus LifeSci Biotech Products ETF (BBP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DVXV achieves a -6.26% return, which is significantly lower than BBP's 5.80% return.


DVXV

1D
1.22%
1M
2.40%
YTD
-6.26%
6M
-6.57%
1Y
3Y*
5Y*
10Y*

BBP

1D
1.18%
1M
-3.14%
YTD
5.80%
6M
7.91%
1Y
45.02%
3Y*
16.70%
5Y*
10.37%
10Y*
11.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DVXV vs. BBP - Yearly Performance Comparison


Correlation

The correlation between DVXV and BBP is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 24, 2025

0.56

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DVXV vs. BBP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DVXV

BBP
BBP Risk / Return Rank: 6565
Overall Rank
BBP Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
BBP Sortino Ratio Rank: 5656
Sortino Ratio Rank
BBP Omega Ratio Rank: 5050
Omega Ratio Rank
BBP Calmar Ratio Rank: 8686
Calmar Ratio Rank
BBP Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVXV vs. BBP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WEBs Health Care XLV Defined Volatility ETF (DVXV) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

DVXV vs. BBP - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


DVXVBBPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.91

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.40

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.42

Sharpe Ratio (All Time)

Calculated using the full available price history

0.75

0.39

+0.36

Drawdowns

DVXV vs. BBP - Drawdown Comparison

The maximum DVXV drawdown since its inception was -14.36%, smaller than the maximum BBP drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for DVXV and BBP.


Loading charts...

Drawdown Indicators


DVXVBBPDifference

Max Drawdown

Largest peak-to-trough decline

-14.36%

-44.32%

+29.96%

Max Drawdown (1Y)

Largest decline over 1 year

-9.28%

Max Drawdown (3Y)

Largest decline over 3 years

-26.09%

Max Drawdown (5Y)

Largest decline over 5 years

-38.28%

Max Drawdown (10Y)

Largest decline over 10 years

-44.32%

Current Drawdown

Current decline from peak

-10.72%

-6.47%

-4.25%

Average Drawdown

Average peak-to-trough decline

-4.79%

-12.02%

+7.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.95%

Volatility

DVXV vs. BBP - Volatility Comparison


Loading charts...

Volatility by Period


DVXVBBPDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.61%

Volatility (6M)

Calculated over the trailing 6-month period

18.43%

Volatility (1Y)

Calculated over the trailing 1-year period

21.33%

23.76%

-2.43%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.33%

26.35%

-5.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.33%

27.40%

-6.07%

DVXV vs. BBP - Expense Ratio Comparison

DVXV has a 0.89% expense ratio, which is higher than BBP's 0.79% expense ratio.


Dividends

DVXV vs. BBP - Dividend Comparison

Neither DVXV nor BBP has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BBP
Virtus LifeSci Biotech Products ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%1.29%
DVXV
WEBs Health Care XLV Defined Volatility ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


DVXV and BBP have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, BBP is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

BBP is cheaper with a 0.79% expense ratio, compared with 0.89% for DVXV.

DVXV and BBP have nearly identical dividend yields, around 0.00%.

DVXV tracks Syntax Defined Volatility XLV Index, while BBP tracks LifeSci Biotechnology Products Index. They also come from different issuers: WEBs and Virtus Investment Partners. Their fees differ too: 0.89% for DVXV and 0.79% for BBP.

Portfolio Optimizer

Find the right allocation for DVXV and BBP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer